Tumor necrosis factor alpha signaling in the development of experimental murine pre-hepatic portal hypertension

Nicholas G. Theodorakis, Yining N. Wang, Jianmin Wu, Mary Maluccio, N. Skill

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The cytokine tumor necrosis factor alpha (TNFa) has previously been identified in the development of portal hypertension (PHT) by facilitating portal venous and systemic hyperemia. TNFa is reported to contribute to hyperemia via endothelial nitric oxide synthase (eNOS) induction and nitric oxide (NO) production. This study examines this hypothesis by utilizing TNFa receptor knockout mice and a murine model of pre-hepatic PHT. Plasma TNFa and NOx and tissue TNFa mRNA levels were determined in wild-type mice 0-7d post induction of pre-hepatic PHT by partial portal vein ligation (PVL). TNFa receptor knockout mice also received PVL or sham surgery and splenic pulp pressure, abdominal aortic flow and portal-systemic shunting were recorded 7d following. Portal pressure and systemic hyperemia developed rapidly following PVL. Plasma NOx was increased temporarily 2-3 days following PVL and returned to baseline by day 7. Circulating TNFa was below detectable limits of the ELISA used, as such no increase was observed. Hepatic and vascular TNFa mRNA levels were transiently changed after PVL otherwise there was no significant change. TNFa receptor targeted gene deletion did not ameliorate plasma NOx following PVL and had no effect on the development of PHT. TNFa receptor signaling plays no detectable role in the development of systemic hyperemia in the murine model of pre-hepatic PHT. Consequently, increased TNFa observed in intra-hepatic inflammatory models (CCl4) and in patients is probably related to inflammation associated with intra-hepatic pathology. Alternatively, TNFa may be signaling via a TNFa receptor independent mechanism.

Original languageEnglish
Pages (from-to)104-110
Number of pages7
JournalInternational Journal of Physiology, Pathophysiology and Pharmacology
Volume2
Issue number2
StatePublished - 2010

Fingerprint

Portal Hypertension
Tumor Necrosis Factor-alpha
Liver
Portal Vein
Tumor Necrosis Factor Receptors
Ligation
Hyperemia
Knockout Mice
Portal Pressure
Messenger RNA
Nitric Oxide Synthase Type III
Gene Deletion
Blood Vessels
Arterial Pressure
Nitric Oxide
Enzyme-Linked Immunosorbent Assay

Keywords

  • Abdominal aortic flow
  • eNOS
  • Hyperemia
  • Knockout
  • Nitric oxide
  • Shunting
  • Splenic pulp pressure
  • TNF alpha

ASJC Scopus subject areas

  • Physiology (medical)
  • Physiology
  • Pathology and Forensic Medicine

Cite this

Tumor necrosis factor alpha signaling in the development of experimental murine pre-hepatic portal hypertension. / Theodorakis, Nicholas G.; Wang, Yining N.; Wu, Jianmin; Maluccio, Mary; Skill, N.

In: International Journal of Physiology, Pathophysiology and Pharmacology, Vol. 2, No. 2, 2010, p. 104-110.

Research output: Contribution to journalArticle

@article{ecdd72caf92840d0b4a80cec06c3262d,
title = "Tumor necrosis factor alpha signaling in the development of experimental murine pre-hepatic portal hypertension",
abstract = "The cytokine tumor necrosis factor alpha (TNFa) has previously been identified in the development of portal hypertension (PHT) by facilitating portal venous and systemic hyperemia. TNFa is reported to contribute to hyperemia via endothelial nitric oxide synthase (eNOS) induction and nitric oxide (NO) production. This study examines this hypothesis by utilizing TNFa receptor knockout mice and a murine model of pre-hepatic PHT. Plasma TNFa and NOx and tissue TNFa mRNA levels were determined in wild-type mice 0-7d post induction of pre-hepatic PHT by partial portal vein ligation (PVL). TNFa receptor knockout mice also received PVL or sham surgery and splenic pulp pressure, abdominal aortic flow and portal-systemic shunting were recorded 7d following. Portal pressure and systemic hyperemia developed rapidly following PVL. Plasma NOx was increased temporarily 2-3 days following PVL and returned to baseline by day 7. Circulating TNFa was below detectable limits of the ELISA used, as such no increase was observed. Hepatic and vascular TNFa mRNA levels were transiently changed after PVL otherwise there was no significant change. TNFa receptor targeted gene deletion did not ameliorate plasma NOx following PVL and had no effect on the development of PHT. TNFa receptor signaling plays no detectable role in the development of systemic hyperemia in the murine model of pre-hepatic PHT. Consequently, increased TNFa observed in intra-hepatic inflammatory models (CCl4) and in patients is probably related to inflammation associated with intra-hepatic pathology. Alternatively, TNFa may be signaling via a TNFa receptor independent mechanism.",
keywords = "Abdominal aortic flow, eNOS, Hyperemia, Knockout, Nitric oxide, Shunting, Splenic pulp pressure, TNF alpha",
author = "Theodorakis, {Nicholas G.} and Wang, {Yining N.} and Jianmin Wu and Mary Maluccio and N. Skill",
year = "2010",
language = "English",
volume = "2",
pages = "104--110",
journal = "International Journal of Physiology, Pathophysiology and Pharmacology",
issn = "1944-8171",
publisher = "e-Century Publishing Corporation",
number = "2",

}

TY - JOUR

T1 - Tumor necrosis factor alpha signaling in the development of experimental murine pre-hepatic portal hypertension

AU - Theodorakis, Nicholas G.

AU - Wang, Yining N.

AU - Wu, Jianmin

AU - Maluccio, Mary

AU - Skill, N.

PY - 2010

Y1 - 2010

N2 - The cytokine tumor necrosis factor alpha (TNFa) has previously been identified in the development of portal hypertension (PHT) by facilitating portal venous and systemic hyperemia. TNFa is reported to contribute to hyperemia via endothelial nitric oxide synthase (eNOS) induction and nitric oxide (NO) production. This study examines this hypothesis by utilizing TNFa receptor knockout mice and a murine model of pre-hepatic PHT. Plasma TNFa and NOx and tissue TNFa mRNA levels were determined in wild-type mice 0-7d post induction of pre-hepatic PHT by partial portal vein ligation (PVL). TNFa receptor knockout mice also received PVL or sham surgery and splenic pulp pressure, abdominal aortic flow and portal-systemic shunting were recorded 7d following. Portal pressure and systemic hyperemia developed rapidly following PVL. Plasma NOx was increased temporarily 2-3 days following PVL and returned to baseline by day 7. Circulating TNFa was below detectable limits of the ELISA used, as such no increase was observed. Hepatic and vascular TNFa mRNA levels were transiently changed after PVL otherwise there was no significant change. TNFa receptor targeted gene deletion did not ameliorate plasma NOx following PVL and had no effect on the development of PHT. TNFa receptor signaling plays no detectable role in the development of systemic hyperemia in the murine model of pre-hepatic PHT. Consequently, increased TNFa observed in intra-hepatic inflammatory models (CCl4) and in patients is probably related to inflammation associated with intra-hepatic pathology. Alternatively, TNFa may be signaling via a TNFa receptor independent mechanism.

AB - The cytokine tumor necrosis factor alpha (TNFa) has previously been identified in the development of portal hypertension (PHT) by facilitating portal venous and systemic hyperemia. TNFa is reported to contribute to hyperemia via endothelial nitric oxide synthase (eNOS) induction and nitric oxide (NO) production. This study examines this hypothesis by utilizing TNFa receptor knockout mice and a murine model of pre-hepatic PHT. Plasma TNFa and NOx and tissue TNFa mRNA levels were determined in wild-type mice 0-7d post induction of pre-hepatic PHT by partial portal vein ligation (PVL). TNFa receptor knockout mice also received PVL or sham surgery and splenic pulp pressure, abdominal aortic flow and portal-systemic shunting were recorded 7d following. Portal pressure and systemic hyperemia developed rapidly following PVL. Plasma NOx was increased temporarily 2-3 days following PVL and returned to baseline by day 7. Circulating TNFa was below detectable limits of the ELISA used, as such no increase was observed. Hepatic and vascular TNFa mRNA levels were transiently changed after PVL otherwise there was no significant change. TNFa receptor targeted gene deletion did not ameliorate plasma NOx following PVL and had no effect on the development of PHT. TNFa receptor signaling plays no detectable role in the development of systemic hyperemia in the murine model of pre-hepatic PHT. Consequently, increased TNFa observed in intra-hepatic inflammatory models (CCl4) and in patients is probably related to inflammation associated with intra-hepatic pathology. Alternatively, TNFa may be signaling via a TNFa receptor independent mechanism.

KW - Abdominal aortic flow

KW - eNOS

KW - Hyperemia

KW - Knockout

KW - Nitric oxide

KW - Shunting

KW - Splenic pulp pressure

KW - TNF alpha

UR - http://www.scopus.com/inward/record.url?scp=77954702240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954702240&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77954702240

VL - 2

SP - 104

EP - 110

JO - International Journal of Physiology, Pathophysiology and Pharmacology

JF - International Journal of Physiology, Pathophysiology and Pharmacology

SN - 1944-8171

IS - 2

ER -